Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Man Hu

Showing results (301-310 of 303) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 303 results.
JAMA Ophthalmology|September 13, 2019
Development and Validation of a Deep Learning System to Detect Glaucomatous Optic Neuropathy Using Fundus PhotographsHanruo Liu, Liu Li, I Michael Wormstone, et al.
Neuro-Oncology Advances|May 29, 2026
An ambispective, observational real-world study of tumor-treating fields for treatment of Chinese patients with newly diagnosed or recurrent/progressive glioblastomaGuanzhang Li, Xiaoguang Qiu, Wei Zhang, et al.
Cancer Letters|August 22, 2025
A multicenter, real-world study analysis: pembrolizumab changes treatment strategy for the patient with recurrent/metastatic head and neck squamous cell carcinomaMan Hu, Xia Li, Hong Feng, et al.
Pageof 31

Showing results (301-310 of 303) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 303 results.
JAMA Ophthalmology|September 13, 2019
Development and Validation of a Deep Learning System to Detect Glaucomatous Optic Neuropathy Using Fundus PhotographsHanruo Liu, Liu Li, I Michael Wormstone, et al.
Neuro-Oncology Advances|May 29, 2026
An ambispective, observational real-world study of tumor-treating fields for treatment of Chinese patients with newly diagnosed or recurrent/progressive glioblastomaGuanzhang Li, Xiaoguang Qiu, Wei Zhang, et al.
Cancer Letters|August 22, 2025
A multicenter, real-world study analysis: pembrolizumab changes treatment strategy for the patient with recurrent/metastatic head and neck squamous cell carcinomaMan Hu, Xia Li, Hong Feng, et al.
Pageof 31